Results 81 to 90 of about 135,105 (102)

Workflow for removal of dislodged leadless pacemaker from distal pulmonary artery: A case report. [PDF]

HeartRhythm Case Rep
Taimur M, Shaheriyar MM, Ali F, Sabeeh E, Naseer A, Hassan SA.   +5 more
europepmc   +1 more source

Late-onset infection of helix-fixation leadless pacemaker diagnosed by pacing threshold elevation and successfully managed with retrieval and reimplantation. [PDF]

HeartRhythm Case Rep
Nakata K, Inamura Y, Ohya H, Takagi T, Matsumura Y, Inaba O.   +5 more
europepmc   +1 more source

Effective and potentially retrievable: will leadless pacemakers become gold standard for pause prevention pacing? [PDF]

Eur Heart J Suppl
Magnani S, Bucci MG, Alì H, Cappato R.
europepmc   +1 more source

Transconduit implantation of an active fixation leadless pacemaker in a patient with intra-atrial Fontan palliation. [PDF]

HeartRhythm Case Rep
Vijayakumar K, Prasitlumkum N, Anderson JH, Asirvatham SJ, Madhavan M, Tan NY.   +5 more
europepmc   +1 more source

Implant efficiency and clinical performance of Aveir™ VR and Micra™ VR leadless pacemaker: A multicenter comparative analysis of 67 patients

PACE - Pacing and Clinical Electrophysiology, 2023
IntroductionLeadless pacemaker (LP) is a novel pacemaker that has been proven to be effective and safe; however, the majority of LPs in previous reports were the Medtronic Micra™ VR LP.
Zulfiqar Qutrio Baloch, Nithi Tokavanich
exaly   +2 more sources

Leadless Versus Transvenous Dual-Chamber Pacemakers: Real-World Evidence From AVEIR DR Coverage With Evidence Development Study

Journal of Cardiovascular Electrophysiology
ABSTRACT Background AVEIR DR, an industry‐first dual‐chamber leadless pacemaker (LP), provides continuous atrioventricular synchrony through implant‐to‐implant (i2i) communication between atrial and ventricular LP devices. It is important to evaluate the early real‐world comparative safety of AVEIR DR LP.
Anish Amin, Leonard Ganz
exaly   +2 more sources